NCT00911768

Brief Summary

The purpose of this study is to determine the effect of KRG (Korean Red Ginseng) on Dry Mouth (Xerostomia).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Sep 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2008

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 3, 2009

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 2, 2009

Completed
Same day until next milestone

Results Posted

Study results publicly available

June 2, 2009

Completed
Last Updated

August 6, 2009

Status Verified

August 1, 2009

Enrollment Period

8 months

First QC Date

March 3, 2009

Results QC Date

March 3, 2009

Last Update Submit

August 3, 2009

Conditions

Keywords

XerostomiaPanax ginseng(Korean Red Ginseng)Visual Analogue ScaleSalivary Flow Rates

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale of Subjective Dry Mouth

    Visual Analogue Scale of Subjective Dry Mouth is 10 cm, where 0 cm indicates no dry mouth and 10 cm the severe dry mouth.

    8 weeks

Secondary Outcomes (2)

  • Stimulated Salivary Flow Rates

    8 weeks

  • Unstimulated Salivary Flow Rates

    8 weeks

Study Arms (2)

Korean Red Ginseng group

EXPERIMENTAL

The brand name of experimental drug is 'Capsule of Korean Red Ginseng Powder'. It consists of the powder of steamed root of Panax ginseng made by Korean Ginseng Corp.

Dietary Supplement: Korean Red Ginseng Powder Capsule

Corn-starch powder with ginseng flavor

PLACEBO COMPARATOR

The placebo of this study is corn-starch powder with Korean Red Ginseng flavor. It has the same shape, color and flavor like experimental drug.

Dietary Supplement: Corn-starch powder with ginseng flavor

Interventions

Generic name: Korean Red Ginseng Powder Capsule Original herb name: Panax ginseng Form and contents: Capsule with powder of steamed root of 6-year Panax ginseng Dosage and frequency: 6 g per day (twice a day), Oral administration Administration duration: 56 days in the study

Also known as: Brand Name: Korean Red Ginseng Powder Capsule
Korean Red Ginseng group

There is no specific name because this intervention is placebo. This placebo has the same form, color and flavor as Korean Red Ginseng Powder Capsule. The dosage form, dosage, frequency and duration is also same as experimental intervention (Korean Red Ginseng Powder Capsule). Main contents: corn-starch with Panax ginseng flavor

Also known as: Corn-starch powder capsule with Korean Red Ginseng flavor
Corn-starch powder with ginseng flavor

Eligibility Criteria

Age19 Years - 76 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Dry mouth patients

You may not qualify if:

  • Sjögren syndrome
  • Irradiation related xerostomia
  • Severe psychiatric diseases
  • pregnancy or breast feeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kyung Hee East-West Neo Medical Center

Seoul, 134-090, South Korea

Location

MeSH Terms

Conditions

Xerostomia

Condition Hierarchy (Ancestors)

Salivary Gland DiseasesMouth DiseasesStomatognathic Diseases

Results Point of Contact

Title
Jae-Woo Park, KMD, PhD
Organization
Kyung Hee East-West Neo Medical Center

Study Officials

  • Jae-Woo Park, K.M.D., Ph.D

    Kyung Hee East-West Neo Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 3, 2009

First Posted

June 2, 2009

Study Start

September 1, 2007

Primary Completion

May 1, 2008

Study Completion

December 1, 2008

Last Updated

August 6, 2009

Results First Posted

June 2, 2009

Record last verified: 2009-08

Locations